September 2015: This quality standard was checked in 2015 to see if it needed updating. Quality statement 3 has been replaced by the quality standard for cardiovascular risk assessment and lipid modification.
This quality standard defines clinical best practice within this topic area. It provides specific, concise quality statements, measures and audience descriptors to provide the public, health and social care professionals, commissioners and service providers with definitions of high-quality care.
This quality standard covers the management of primary hypertension in adults, including diagnosis and investigations, treatment to reduce risk of cardiovascular disease, monitoring of treatment efficacy, and specialist referral.
It was previously called the quality standard for hypertension.